(Q34092415)

31 July 2017

A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides (English)

1 reference

31 July 2017

1 reference

Streptococcus pneumoniae

1 reference

1 reference

Quataert S

1

1 reference

31 July 2017

Martin D

2

1 reference

31 July 2017

Anderson P

3

1 reference

31 July 2017

Giebink GS

4

1 reference

31 July 2017

Henrichsen J

5

1 reference

31 July 2017

Leinonen M

6

1 reference

31 July 2017

Granoff DM

7

1 reference

31 July 2017

Russell H

8

1 reference

31 July 2017

Siber G

9

1 reference

31 July 2017

Faden H

10

1 reference

31 July 2017

Barnes D

11

1 reference

31 July 2017

Madore DV

12

1 reference

31 July 2017

1 August 2001

1 reference

Immunological Investigations

31 July 2017

1 reference

31 July 2017

30

1 reference

31 July 2017

3

1 reference

31 July 2017

191-207

1 reference

Pneumococcal disease: prospects for a new generation of vaccines

31 July 2017

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Serotypes of Streptococcus pneumoniae Causing Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

A global gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Epidemiology of invasive pneumococcal infections in children in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Antibody titers eight months after three doses of a five-valent pneumococcal conjugate vaccine in HIV and non-HIV-infected children less than two years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FIMM-100105064

21 January 2018

Identifiers

DOI

10.1081/IMM-100105064

1 reference

31 July 2017

1 reference